ESC 365 - Genetic correction of phospholamban mutations in vitro and in vivo human-based models

CBS PREMIUM ACCESS

Genetic correction of phospholamban mutations in vitro and in vivo human-based models

Session: Gene editing for the heart: progress and hurdles

Topic: Genetics, Epigenetics, ncRNA

Speaker: Doctor F. Stillitano (Utrecht, NL)

Event: Frontiers in CardioVascular Biomedicine 2022

Congress Presentation

Add to my library

About the speaker

Doctor Francesca Stillitano

University Medical Center Utrecht, Utrecht (Netherlands (The))

2 presentations

0 follower

3 more presentations in this session

Genetic correction of phospholamban mutations in small and large animal models

Speaker: Professor C. Kupatt (Munich, DE)

Delivering the editors to the heart

Speaker: Professor M. Giacca (London, GB)

Gene editing for the heart: progress and hurdles – discussion

Access the full session

Gene editing for the heart: progress and hurdles

Speakers: Doctor F. Stillitano, Professor C. Kupatt, Professor M. Giacca

About the event

Frontiers in CardioVascular Biomedicine 2022

29 April - 1 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources